Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.

Alzpath said Monday that it has licensed a proprietary Alzheimer's disease biomarker to Siemens Healthineers for use in an assay for the brain disorder. The deal covers an antibody to ...

Jefferies analyst Tycho Peterson cited the large addressable market for the company's PreTRM blood test for assessing pregnant women's risk of preterm birth.

Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.

The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.

The collaboration combines Guardant's diagnostics with Trial Library's AI-powered matching and patient navigation platform.

With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.

NEW YORK – With its $275 million buy of Foresight Diagnostics announced last week, Natera plans to expand into the hematological oncology market and boost sensitivity of its flagship Signatera solid ...

CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...